PRESS RELEASES
Exact Imaging and Riverside Research form Strategic Partnership to develop advanced tissue characterization techniques for detection of prostate cancer
Partnership aims to apply Riverside Research’s algorithm expertise to the ExactVu™ micro-ultrasound imaging platform for real-time prostate imaging

TORONTO, ON and NEW YORK, NY -- (October 20, 2015) Exact Imaging (www.exactimaging.com), the world’s leader in high–resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance of the prostate, announced a strategic partnership with Riverside Research, a leading not-for-profit, scientific-research company. The partnership will seek to apply Riverside Research’s patented, quantitative, tissue- characterization algorithms to the ExactVu™ high–resolution micro-ultrasound platform to develop new capabilities in the system’s ability to detect and characterize prostate cancer.

“Urologists are demanding more from their imaging tools because current ultrasound systems do not have sufficient resolution to visualize and target biopsies of suspicious regions,” says Randy AuCoin, Exact Imaging’s President and CEO. “Our ExactVu micro-ultrasound system enables a new paradigm in real-time imaging resolution - - a 300% improvement in resolution compared to conventional ultrasound. This advance will allow urologists to clearly visualize and target suspicious regions for biopsy, in addition to performing systematic biopsy protocols. With the addition of Riverside Research’s novel, quantitative, tissue-characterization techniques, we will continue to develop new applications and workflows to help clinicians further identify and characterize these suspicious regions. The ultimate goal is to improve the clinical outcomes enabled through micro-ultrasound-based prostate imaging and biopsies.”

“We are very excited about applying our extensive experience in ultrasound-based tissue characterization and tissue-type imaging to the ultra-high frequencies enabled by the ExactVu system to explore novel possibilities in differentiating healthy from disease prostate tissue,” says Dr. Ernest Feleppa, Director of the Lizzi Center for Biomedical Engineering at Riverside Research. “The rich data generated at these ultra-high resolutions allows us to improve the accuracy of our quantitative ultrasound methods for differentiating cancerous from noncancerous tissue in the prostate. Ultrasound is the global standard of care for urological imaging, and we expect that combining micro-ultrasound’s resolution and enhanced information content with our tissue-characterization algorithms will yield very exciting new insights and, ultimately, improved clinical outcomes.”

About Exact Imaging (formerly Imagistx):

Exact Imaging (www.exactimaging.com) is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies in the urological market for prostate cancer. Operating up to 29 MHz, the ExactVu™ micro-ultrasound platform enables a whole new level of resolution comparable to MRI but with the benefits of ease of use, affordability, and being an extension of the current urological workflow. Using the Exact Imaging platform, urologists will now be able to visualize suspicious areas in the prostate and specifically target biopsies at those areas in addition to performing systematic, trans-rectal, ultrasound biopsy protocols. ExactVu™ micro-ultrasound system has CE marking (Certificate #649960) for sale in the European Union. The product is not yet commercially available in the US and Canada.

About Riverside Research

Riverside Research is a not-for-profit organization chartered to advance scientific research in the public interest and in support of the United States government. Comprised of leading engineering, technology, and operations experts, Riverside Research delivers trusted solutions in Biomedical Engineering, Cyber, Electromagnetic Sciences, and Intelligence, Surveillance, and Reconnaissance. These Centers of Excellence are supported by five integrated research laboratories that conduct independent and mission-focused research in critical technology areas. Originating as part of Columbia University in the 1950s and established as an independent corporation in 1967, Riverside Research remains dedicated to its academic heritage by working with colleges and universities from across the nation to advance science, technology, engineering, and math through education, research, and workforce development.
Learn more at www.riversideresearch.org.

For further information, please contact:
Robert Sandler
SVP, Marketing
Exact Imaging
T. +1.416.274.8166
E. rsandler@exactimaging.com
www.exactimaging.com
2018

2017

2016

2015



© 2018 Exact imaging
ExactVu™, Exact Imaging™, PRI-MUS™, FusionVu™, Cognitive Assist™ and ExactVu Micro Doppler™ are trademarks of Exact Imaging.
ExactVu™ micro-ultrasound system is available for sale in the European Union (CE Mark), the United States (FDA 510(k) clearance), and in Canada (Health Canada license).